Management of Arrhythmias in COVID-19

Creative Commons License

ŞENER Y. Z., CANPOLAT U., YORGUN H., AYTEMİR K.

EURASIAN JOURNAL OF EMERGENCY MEDICINE, vol.21, no.1, pp.1-7, 2022 (ESCI) identifier identifier

  • Publication Type: Article / Review
  • Volume: 21 Issue: 1
  • Publication Date: 2022
  • Doi Number: 10.4274/eajem.galenos.2020.27880
  • Journal Name: EURASIAN JOURNAL OF EMERGENCY MEDICINE
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1-7
  • Keywords: COVID-19, cardiac arrhythmia, QT prolongation, NASOGASTRIC TUBE, QT, LONG, PROLONGATION
  • Hacettepe University Affiliated: Yes

Abstract

Coronavirus disease-2019 (COVID-19) disease is caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) virus infection and firstly appeared in China and then became a pandemic. The leading cause of mortality is respiratory failure in COVID-19; however, cardiovascular manifestations are frequent and also important causes of death in COVID-19. The incidence of arrhythmia is increased in patients with COVID-19 due to increased systemic inflammatory response, hypoxia, and administered drugs. All kinds of arrhythmias, including bradyarrhythmias, supraventricular and ventricular arrhythmias, may develop during COVID-19 course. QT prolongation plays a central role in COVID-19 related arrhythmias. Therefore, QT duration should be strictly followed. All the clinicians should know the management of arrhythmias that they might face with frequently during the pandemic.